Junction key facts
as of Oct 2026- Developer of a healthcare infrastructure platform intended to simplify application development and integration in the medical field.
- Junction is valued at approximately $90.0M as of Oct 2026 (last reported valuation).
- It has raised $21.0M; the latest was Early Stage VC ($18.0M) in Mar 2025.
- Notable investors include Y Combinator, Gaingels, 20VC, Creandum, Point Nine Capital — 14 tracked in total.
- Status: Privately Held (backing).
Junction's last reported valuation, Mar 2025. Nothing priced has surfaced since.
- ·The complete investor list: 14 names
- ·Watch Junction: the Monday email on marks, rounds and moves
Junction funding rounds
No funding rounds for Junction are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Junction
14+Membership and data by Private Market View
Junction valuation
Junction's last reported valuation was $90 million in Mar 2025. No priced round, secondary trade or fund mark has surfaced since.
Junction investors
14 investors are on record for Junction, including Y Combinator, Gaingels, 20VC and Creandum. By type, the record holds 4 venture capital firms and 1 angel investor.
About Junction
Developer of a healthcare infrastructure platform intended to simplify application development and integration in the medical field. The company's tool facilitates the collection of health and fitness data, links with medical devices and a nationwide laboratory network, and enables remote patient monitoring while also providing automated workflows and compliance support to enhance efficiency, enabling developers to unify diverse data sources within a single system.
- Sector
- Information Technology
- HQ
- New York, NY, United States
- Founded
- 2021
- Employees
- 26
- Website
- junction.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.